Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model

被引：0
作者：
Said Ahmed Bahwal
Jane J. Chen
Lilin E
Taofang Hao
Jiancong Chen
Vern B. Carruthers
Jiaming Lai
Xingwang Zhou
机构：
[1] Sun Yat-Sen University,Department of Biochemistry and Molecular Biology, Sun Yat
[2] Warren Alpert Medical School of Brown University,Sen University Zhongshan School of Medicine
[3] Sun Yat-Sen University,Department of Pancreato
[4] University of Michigan School of Medicine,Biliary Surgery, The First Affiliated Hospital
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Dendritic cells; Immunotherapy; Programmed cell death 1 receptor; Vaccination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2743 / 2757
页数：14
相关论文
共 50 条
  • [31] Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer
    Bommireddy, Ramireddy
    Munoz, Luis E.
    Kumari, Anita
    Huang, Lei
    Fan, Yijian
    Monterroza, Lenore
    Pack, Christopher D.
    Ramachandiran, Sampath
    Reddy, Shaker J. C.
    Kim, Janet
    Chen, Zhuo G.
    Saba, Nabil F.
    Shin, Dong M.
    Selvaraj, Periasamy
    VACCINES, 2020, 8 (02)
  • [32] Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
    Garofalo, Mariangela
    Bertinato, Laura
    Staniszewska, Monika
    Wieczorek, Magdalena
    Salmaso, Stefano
    Schrom, Silke
    Rinner, Beate
    Pancer, Katarzyna Wanda
    Kuryk, Lukasz
    PHARMACEUTICS, 2021, 13 (04)
  • [33] Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer
    Gong, Xiaomei
    Li, Xuefei
    Jiang, Tao
    Xie, Huikang
    Zhu, Zhengfei
    Zhou, Fei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (07) : 1085 - 1097
  • [34] Notch signaling inhibitor and anti-PD-L1 antibody combination therapies decelerate tumor progression in pancreatic cancer
    Dai, Hongmei
    Hong, Xiafei
    Huang, Dan
    Wu, Huanwen
    Wang, Xianze
    Chen, Hao
    Jiang, Rui
    Chen, Wenyan
    Zhao, Yupei
    Wu, Wenming
    JOURNAL OF PANCREATOLOGY, 2021, 4 (02) : 106 - 114
  • [35] In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model
    Kim, Yoomin
    Jeon, Seung Hyuck
    Kim, Seongmin
    Kang, Mi Hyun
    Han, Min Guk
    Lee, Se Yup
    Kim, In Ah
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [36] CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models
    Lv, Zhuangwei
    Zhang, Ping
    Li, Dandan
    Qin, Mengting
    Nie, Longzhu
    Wang, Xiaoqian
    Ai, Li
    Feng, Zhaozu
    Odhiambo, Woodvine Otieno
    Ma, Yunfeng
    Ji, Yanhong
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [37] Antitumor effect of proton beam irradiation and anti-PD-L1 antibody combination therapy in subcutaneous murine models of pancreatic cancer
    Nasti, Alessandro
    Sakai, Yoshio
    Ogawa, Norihiko
    Miyazawa, Masaki
    Inagaki, Shingo
    Ho, Tuyen Thuy Bich
    Nomura, Hiroki
    Seki, Akihiro
    Kume, Kyo
    Maeda, Munetoshi
    Sasaki, Makoto
    Kaneko, Shuichi
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 396 - 396
  • [38] Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models
    Xu, Chunxiao
    Zhang, Yanping
    Rolfe, P. Alexander
    Hernandez, Vivian M.
    Guzman, Wilson
    Kradjian, Giorgio
    Marelli, Bo
    Qin, Guozhong
    Qi, Jin
    Wang, Hong
    Yu, Huakui
    Tighe, Robert
    Lo, Kin-Ming
    English, Jessie M.
    Radvanyi, Laszlo
    Lan, Yan
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5869 - 5880
  • [39] Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis
    Ho, Tuyen Thuy Bich
    Nasti, Alessandro
    Seki, Akihiro
    Komura, Takuya
    Inui, Hiiro
    Kozaka, Takashi
    Kitamura, Yoji
    Shiba, Kazuhiro
    Yamashita, Taro
    Yamashita, Tatsuya
    Mizukoshi, Eishiro
    Kawaguchi, Kazunori
    Wada, Takashi
    Honda, Masao
    Kaneko, Shuichi
    Sakai, Yoshio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [40] CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial
    Montagne, Janelle M.
    Mitchell, Jacob T.
    Tandurella, Joseph A.
    Christenson, Eric S.
    Danilova, Ludmila, V
    Deshpande, Atul
    Loth, Melanie
    Sidiropoulos, Dimitrios N.
    Davis-Marcisak, Emily
    Bergman, Daniel R.
    Zhu, Qingfeng
    Wang, Hao
    Kagohara, Luciane T.
    Engle, Logan L.
    Green, Benjamin F.
    Favorov, Alexander, V
    Ho, Won Jin
    Lim, Su Jin
    Zhang, Rui
    Li, Pan
    Gai, Jessica
    Mo, Guanglan
    Mitchell, Sarah
    Wang, Rulin
    Vaghasia, Ajay
    Hou, Wenpin
    Xu, Yao
    Zimmerman, Jacquelyn W.
    Elisseeff, Jennifer H.
    Yegnasubramanian, Srinivasan
    Anders, Robert A.
    Jaffee, Elizabeth M.
    Zheng, Lei
    Fertig, Elana J.
    ISCIENCE, 2025, 28 (01)
12345